Dextran-based Nanocarriers for Delivery of Bioactives
Related Experiment Video
Updated: Mar 26, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
Published on: March 17, 2023
Rania A H Ishak, Rihab Osman1, Gehanne A S Awad
1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University. African organization Unity Street, Cairo, Egypt. rihabosman@pharma.asu.edu.eg.
Background:
Dextran (DX) is a natural polysaccharide produced in the laboratory by fermentation of sucrose under the effect of the enzyme DX sucrase (1,6-α-D-glucan-α- glucosyltransferase). After harvesting and purification DX is subjected to cracking and separation to obtain the desired molecular weight.
Methods:
The hydroxyl groups present in DX offer many sites for derivatization allowing the production of functionalized glycoconjugates biocompatible compound. DX and its derivatives are getting increased attention for use in core decoration or as carriers in novel drug delivery systems. This includes, among others, ion-pairing, self-aggregate, protein and drug conjugates. DX carriers and camouflaged particles will be dealt with in this review to give emphasis on the great versatility of this natural biocompatible polysaccharide.
Conclusion:
With the continuous development in the area of drug delivery, we believe that the unique properties of this versatile nanocarrier platform will elect it as one of the cornerstones of safe nanodelivery systems.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Bioavailability
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Delivery Systems: Different Types

